Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT00122551
Eligibility Criteria:
Inclusion Criteria:
* HIV-1 infection
* CD4 cell count over 450/µl for at least 6 months prior to screening
* Plasma HIV1-RNA below 200 cop/ml for at least 6 months prior to screening
* Stable and well tolerated ART for at least 6 months prior to screening
* Acceptable methods of contraception
* Patient able to comply with the protocol
* Informed consent signed prior to (or at) screening
Exclusion Criteria:
* CD4 nadir below 100/µl
* Abacavir or nevirapine in the current ART
* Hepatitis B with 3-TC, adefovir or tenofovir current therapy
* Current or upcoming treatment with interferon for hepatitis B or C
* History of AIDS-defining event in the 18 months prior to screening
* Pregnancy or breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00122551
Study Brief:
Protocol Section:
NCT00122551